The companies recently announced the successful completion of the collaboration’s third year.
As part of the extension, Evogene will add its Gene2Product computational technologies to its gene discovery program, offering an additional approach for enhancing trait efficacy and the development of candidate genes identified under the collaboration.
Ofer Haviv, Evogene’s president and CEO, said: “We are delighted by this extension of our joint work with Monsanto and in particular with the addition of our Gene2Product computational technologies. We expect that by bringing together Monsanto’s development expertise and these new Evogene technologies, in addition to those already utilised in the collaboration, the companies will be able to further address some of the key challenges that the seed industry is facing in the discovery and development process for biotechnology products in agriculture.”
Source: Monsanto
© FoodBev Media Ltd 2024